Xylem (XYL) PT Lowered to $166 at Barclays
Tweet
Share
E-mailGet Alerts XYL Hot Sheet
Price: $113.94 --0%
Rating Summary:
17 Buy, 24 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
17 Buy, 24 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
Barclays analyst William Grippin lowered the price target on Xylem (NYSE: XYL) to $166.00 (from $172.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Invesco Mortgage Capital (IVR) PT Lowered to $7.75 at UBS
- Hesai (2525:HK) (HSAI) PT Lowered to HK$29 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
